SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nuveen New Jersey Quality Municipal Income Fund (NXJ) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 32/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NXJ
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$42.71M |
$-17.48M |
-40.9% |
| 2017 |
$0.86 |
$37.14M |
$36.48M |
98.2% |
| 2018 |
$0.80 |
$34.27M |
$33.68M |
98.3% |
| 2019 |
$2.28 |
$95.15M |
$94.68M |
99.5% |
| 2020 |
$-0.01 |
$-16.44K |
$-490.71K |
- |
| 2021 |
$-0.25 |
$-9.88M |
$-10.29M |
- |
| 2022 |
$-1.57 |
$-64.7M |
$-65.14M |
- |
| 2023 |
$0.90 |
$36M |
$37.15M |
103.2% |
| 2024 |
$0.09 |
$18.58M |
$3.68M |
19.8% |
| 2025 |
$0.00 |
$-4.51M |
$-19.71M |
- |